Literature DB >> 21337569

Oncoplastics: techniques for reconstruction of partial breast defects based on tumor location.

Sarah M Gainer1, Anthony Lucci.   

Abstract

Breast conservation therapy (BCT) has become an increasingly popular treatment for breast cancer. Unfortunately, many women who undergo BCT will have a deformity that may require surgical correction. The field of oncoplastics has also become increasingly popular and seeks to prevent these contour deformities during BCT. This review approaches oncoplastic reconstruction by outlining different techniques based on tumor location.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21337569     DOI: 10.1002/jso.21672

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  5 in total

1.  "Diamond" mammoplasty as a part of conservative management of breast cancer: Description of a new technique.

Authors:  Osama Hussein; Tawfik El-Khodary
Journal:  Int J Surg Case Rep       Date:  2012-03-07

2.  Oncoplastic Reduction Pattern Technique Following Removal of Giant Fibroadenoma.

Authors:  Andrea Hiller; Thomas J Lee; Joshua Henderson; Nicolas Ajkay; Bradon J Wilhelmi
Journal:  Eplasty       Date:  2018-01-22

3.  Retrospective review of 108 breast reconstructions using the round block technique after breast-conserving surgery: Indications, complications, and outcomes.

Authors:  Seok Kyung In; Yoon Soo Kim; Ho Sung Kim; Jin Hyung Park; Hong Il Kim; Hyung Suk Yi; Jea Chun Park; Chang Wan Jeon; Jin Hyuk Choi; Sung Ui Jung; Hyo Young Kim
Journal:  Arch Plast Surg       Date:  2020-11-15

Review 4.  Treatment and Survivorship Interventions to Prevent Poor Body Image Outcomes in Breast Cancer Survivors.

Authors:  Caroline Fiser; Jessica S Crystal; Sarah E Tevis; Susan Kesmodel; Kristin E Rojas
Journal:  Breast Cancer (Dove Med Press)       Date:  2021-12-16

Review 5.  Surgery on primary melanoma of the breast.

Authors:  Qi Huang; Xiao-Hua Zhang; Ling-Ji Guo; Yu-Jun He
Journal:  Transl Cancer Res       Date:  2019-10       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.